330 related articles for article (PubMed ID: 33790024)
1. Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy.
Liu X; Hartman CL; Li L; Albert CJ; Si F; Gao A; Huang L; Zhao Y; Lin W; Hsueh EC; Shen L; Shao Q; Hoft DF; Ford DA; Peng G
Sci Transl Med; 2021 Mar; 13(587):. PubMed ID: 33790024
[TBL] [Abstract][Full Text] [Related]
2. Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy.
Liu X; Si F; Bagley D; Ma F; Zhang Y; Tao Y; Shaw E; Peng G
J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36192086
[TBL] [Abstract][Full Text] [Related]
3. TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy.
Li L; Liu X; Sanders KL; Edwards JL; Ye J; Si F; Gao A; Huang L; Hsueh EC; Ford DA; Hoft DF; Peng G
Cell Metab; 2019 Jan; 29(1):103-123.e5. PubMed ID: 30344014
[TBL] [Abstract][Full Text] [Related]
4. Senescent T cells within suppressive tumor microenvironments: emerging target for tumor immunotherapy.
Liu X; Hoft DF; Peng G
J Clin Invest; 2020 Mar; 130(3):1073-1083. PubMed ID: 32118585
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T cells trigger effector T cell DNA damage and senescence caused by metabolic competition.
Liu X; Mo W; Ye J; Li L; Zhang Y; Hsueh EC; Hoft DF; Peng G
Nat Commun; 2018 Jan; 9(1):249. PubMed ID: 29339767
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived γδ regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence.
Ye J; Ma C; Hsueh EC; Eickhoff CS; Zhang Y; Varvares MA; Hoft DF; Peng G
J Immunol; 2013 Mar; 190(5):2403-14. PubMed ID: 23355732
[TBL] [Abstract][Full Text] [Related]
7. Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment.
Zhao Y; Shao Q; Peng G
Cell Mol Immunol; 2020 Jan; 17(1):27-35. PubMed ID: 31853000
[TBL] [Abstract][Full Text] [Related]
8. TLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence.
Ye J; Ma C; Hsueh EC; Dou J; Mo W; Liu S; Han B; Huang Y; Zhang Y; Varvares MA; Hoft DF; Peng G
EMBO Mol Med; 2014 Oct; 6(10):1294-311. PubMed ID: 25231413
[TBL] [Abstract][Full Text] [Related]
9. Human regulatory T cells induce T-lymphocyte senescence.
Ye J; Huang X; Hsueh EC; Zhang Q; Ma C; Zhang Y; Varvares MA; Hoft DF; Peng G
Blood; 2012 Sep; 120(10):2021-31. PubMed ID: 22723548
[TBL] [Abstract][Full Text] [Related]
10. The role of lipid metabolic reprogramming in tumor microenvironment.
Yang K; Wang X; Song C; He Z; Wang R; Xu Y; Jiang G; Wan Y; Mei J; Mao W
Theranostics; 2023; 13(6):1774-1808. PubMed ID: 37064872
[TBL] [Abstract][Full Text] [Related]
11. Remodeling of the tumor microenvironment via disrupting Blimp1
Dixon ML; Luo L; Ghosh S; Grimes JM; Leavenworth JD; Leavenworth JW
Mol Cancer; 2021 Nov; 20(1):150. PubMed ID: 34798898
[TBL] [Abstract][Full Text] [Related]
12. Δ133p53α enhances metabolic and cellular fitness of TCR-engineered T cells and promotes superior antitumor immunity.
Legscha KJ; Antunes Ferreira E; Chamoun A; Lang A; Awwad MHS; Ton GNHQ; Galetzka D; Guezguez B; Hundemer M; Bourdon JC; Munder M; Theobald M; Echchannaoui H
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34112738
[TBL] [Abstract][Full Text] [Related]
13. Connecting the Dots: Therapy-Induced Senescence and a Tumor-Suppressive Immune Microenvironment.
Vilgelm AE; Johnson CA; Prasad N; Yang J; Chen SC; Ayers GD; Pawlikowski JS; Raman D; Sosman JA; Kelley M; Ecsedy JA; Shyr Y; Levy SE; Richmond A
J Natl Cancer Inst; 2016 Jun; 108(6):djv406. PubMed ID: 26719346
[TBL] [Abstract][Full Text] [Related]
14. Senescent T cells: a potential biomarker and target for cancer therapy.
Zhang J; He T; Xue L; Guo H
EBioMedicine; 2021 Jun; 68():103409. PubMed ID: 34049248
[TBL] [Abstract][Full Text] [Related]
15. Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity.
Punt S; Malu S; McKenzie JA; Manrique SZ; Doorduijn EM; Mbofung RM; Williams L; Silverman DA; Ashkin EL; Dominguez AL; Wang Z; Chen JQ; Maiti SN; Tieu TN; Liu C; Xu C; Forget MA; Haymaker C; Khalili JS; Satani N; Muller F; Cooper LJN; Overwijk WW; Amaria RN; Bernatchez C; Heffernan TP; Peng W; Roszik J; Hwu P
Cancer Immunol Immunother; 2021 Apr; 70(4):1101-1113. PubMed ID: 33123754
[TBL] [Abstract][Full Text] [Related]
16. [Cholesterol Metabolism and Tumor Immunity].
Luo N; Shi RC; Dai RY; Miao HM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 53(2):335-341. PubMed ID: 35332739
[TBL] [Abstract][Full Text] [Related]
17. Amino acid metabolism reprogramming: shedding new light on T cell anti-tumor immunity.
Zheng Y; Yao Y; Ge T; Ge S; Jia R; Song X; Zhuang A
J Exp Clin Cancer Res; 2023 Nov; 42(1):291. PubMed ID: 37924140
[TBL] [Abstract][Full Text] [Related]
18. T cell senescence: a new perspective on immunotherapy in lung cancer.
Huang M; Wang Y; Fang L; Liu C; Feng F; Liu L; Sun C
Front Immunol; 2024; 15():1338680. PubMed ID: 38415245
[TBL] [Abstract][Full Text] [Related]
19. Targeting CCR8 Induces Protective Antitumor Immunity and Enhances Vaccine-Induced Responses in Colon Cancer.
Villarreal DO; L'Huillier A; Armington S; Mottershead C; Filippova EV; Coder BD; Petit RG; Princiotta MF
Cancer Res; 2018 Sep; 78(18):5340-5348. PubMed ID: 30026324
[TBL] [Abstract][Full Text] [Related]
20. Citrate Promotes Excessive Lipid Biosynthesis and Senescence in Tumor Cells for Tumor Therapy.
Zhao Y; Liu X; Si F; Huang L; Gao A; Lin W; Hoft DF; Shao Q; Peng G
Adv Sci (Weinh); 2022 Jan; 9(1):e2101553. PubMed ID: 34747157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
